February 17, 2004Open Access

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

Key Points

Key points are not available for this paper at this time.

Abstract

Despite the fact that the biologic phenotype of ILC is quite favorable, these patients do not have better clinical outcomes than do patients with IDC. At present, management decisions should be based on individual patient and tumor biologic characteristics, and not on lobular histology.

AIに質問

Bookmark

View Full Paper

Cite This Study

Arpino et al. (Tue,) studied this question.

synapsesocial.com/papers/69d78ebe3fae90fd6048fc11 https://doi.org/https://doi.org/10.1186/bcr767

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns1996 · 424 citations
2Correlation of HER-2/neu Amplification With Expression and With Other Prognostic Factors in 1103 Breast Cancers1992 · 105 citations
3Association of leptomeningeal carcinomatosis in carcinoma of the breast with infiltrating lobular carcinoma. An autopsy study.1991 · 48 citations
4An analysis of prognostic features in infiltrating lobular carcinoma of the breast.1995 · 15 citations
5Lobular Carcinoma of the Female Breast1966 · 110 citations

AIに質問

Bookmark

View Full Paper